Business Context and Reporting Period
This Form 8-K is a current report filed by Trovagene, Inc. (not Cardiff Oncology, Inc.) on March 21, 2017. The filing reports an "Other Event" under Item 8.01 regarding an upcoming investor presentation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is informational and does not contain financial statements or performance data.
Material Changes
No material financial changes or operational updates are disclosed in this filing. The sole event reported is the scheduling of a corporate presentation.
Guidance, Outlook, and Management Commentary
- Upcoming Event: CEO Bill Welch is scheduled to present at the Sidoti & Company Spring 2017 Convention.
- Date and Time: March 29, 2017, at 9:15 AM EDT.
- Details: A copy of the press release announcing this event is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the company name is Trovagene, Inc., not Cardiff Oncology, Inc.
- Confirm the presentation date (March 29, 2017) and time (9:15 AM EDT) for the Sidoti & Company Spring 2017 Convention.
- Review Exhibit 99.1 for the full text of the press release regarding the presentation.
- Note that no financial data or guidance is contained within this specific 8-K filing.